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ABSTRACT Ca21 efﬂux from the sarcoplasmic reticulum decreases when store Ca21 concentration falls, particularly in skinned
ﬁbers and isolated vesicles where luminal Ca21 can be reduced to very low levels. However ryanodine receptor activity in many
single channel studies is higher when the luminal free Ca21 concentration is reduced. We investigated the hypothesis that
prolongedexposure to low luminalCa21 causes conformational changes in calsequestrin andderegulation of ryanodine receptors,
allowing channel activity to increase. Lowering of luminal Ca21 from1mM to 100mM for severalminutes resulted in conformational
changeswith dissociation of 65–75%of calsequestrin from the junctional facemembrane. The calsequestrin remaining associated
no longer regulated channels. In the absence of this regulation, ryanodine receptors were more active when luminal Ca21 was
lowered from 1 mM to 100 mM. In contrast, when ryanodine receptors were calsequestrin regulated, lowering luminal Ca21 either
did not alter or decreased activity. Ryanodine receptors are regulated by calsequestrin under physiological conditions where
calsequestrin is polymerized. Since depolymerization occurs slowly, calsequestrin can regulate the ryanodine receptor and
prevent excess Ca21 release when the store is transiently depleted, for example, during high frequency activity or early stages of
muscle fatigue.
INTRODUCTION
In this study we address the effect of low luminal Ca21 on
the conformation of the Ca21-binding protein calsequestrin
(CSQ) and on its ability to regulate the ryanodine receptor
(RyR) Ca21 release channel. We also address the way in which
this regulation may deﬁne the RyRs response to a fall in
luminal [Ca21]. Ca21 release from the sarcoplasmic retic-
ulum (SR) of skeletal and cardiac muscle ﬁbers is determined
by the amount of Ca21 that is loaded into the store under
resting conditions (1–4). Store-dependent Ca21 release is
also found in many other cell types (5–7). The effect of store
load on Ca21 release is particularly apparent in isolated
skinned muscle ﬁbers or SR vesicle preparations where store
Ca21 can be reduced to very low concentrations (4–8). In
contrast to the consistent results with whole cell and vesicle
studies, RyR channels in lipid bilayer systems have been
found to respond in a variety of ways to changes in luminal
[Ca21]. For example, changing luminal Ca21 between 0.5 or
50 mM to ;1 mM either activates, inhibits, or causes bi-
phasic changes in RyR activity (9–13). These different re-
sponses do not appear to be correlated with the use of native
or puriﬁed RyRs or with the presence of the cytoplasmic
channel activators Ca21 or ATP but may be due to the pres-
ence or absence of Ca21-sensitive proteins on the luminal
side of the channel. It is known that there are sensors for
[Ca21] on the RyR protein and/or on luminal proteins that
are associated with the RyR (13–15). Little is known about
these Ca21 detectors or the interactions between them and
the RyR.
CSQ is the major Ca21-binding protein in the lumen of the
SR where it forms a linear polymer that is seen to be closely
associated with the junctional face membrane in ultrastruc-
tural images (16). CSQ inhibits the RyR when anchoring
proteins triadin and junctin are present (15,17,18). Triadin
and junctin are both transmembrane proteins which bind to
CSQ and the RyR to form a stable quaternary (RyR/Tri/Jun/
CSQ) complex (19). CSQ is a prime candidate for a luminal
[Ca21]-detector because Ca21 stabilizes CSQ conformation
and the CSQ polymer (20). Although CSQ binds to triadin
and junctin when [Ca21]s are lowered (19), reducing luminal
[Ca21] may destabilize the CSQ polymer and alter the way in
which it inﬂuences RyR activity. Several lines of evidence
support this theory. First, we have shown that the RyR/Tri/
Jun/CSQ complex facilitates the response of the skeletal
RyR to increases in luminal [Ca21] from 1 to 10 mM (21).
Second, a reconstituted RyR/Tri/Jun/CSQ complex is nec-
essary for the cardiac RyR to respond to an increase in
luminal Ca21 from 20 mM to 5 mM (15). Cardiac CSQ exists
as a monomer when the [Ca21] is low (22). Cardiac and
skeletal CSQ are the products of different genes and contain
sequence differences in the proposed Ca21-binding sites
(23,24). The response of skeletal CSQ to changes in luminal
Ca21 between 100 nM and 1 mM has not been reported pre-
viously, to our knowledge.
We have examined the effects of luminal Ca21 on the
conformation of CSQ and the ability of the Ca21-binding
protein to regulate the RyR under conditions where CSQ ex-
ists either mostly as a multimer or mostly as a monomer.
Luminal [Ca21] was varied between physiological levels of
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1 mM and lower levels (100 mM, 1 mM, or 100 nM).
Lowering luminal [Ca21] resulted in conformational changes
in CSQ, with a reduction in the amount of CSQ polymer and
an increase in monomer content. In addition, a reduction in
luminal [Ca21] caused a slow dissociation of a fraction of
CSQ from the junctional face membrane and a loss of CSQ
regulation of RyR activity. When CSQ was either fully
dissociated from the RyR (by high ionic strength (25)) or
unable to regulate the channel (at low luminal Ca21—results
from this study), the channels were rapidly activated by
lowering luminal Ca21 to nanomolar levels. When RyRs
were not subjected to CSQ-dissociation/deregulation proce-
dures, channel activity was either initially unchanged or
rapidly reduced by lowering luminal [Ca21], depending on
the degree of cytoplasmic Ca21 activation. The results sug-
gest that a), CSQ protects the Ca21 stores from excess Ca21
depletion by reducing RyR activity when the luminal [Ca21]
is lower than the physiological concentration (;1 mM), and
b), the ability of CSQ to perform this function depends on it
maintaining its native polymer conformation. The data also
suggest that CSQ is only one of several [Ca21] detectors on
the luminal side of the skeletal muscle RyR. Taken together
with our previous studies (26), the effects of CSQ on the
RyR suggest that the Ca21-binding protein would enhance
the increase in Ca21 release from the SR when the store is
fully loaded but protects the SR from Ca21 depletion when
the Ca21 load falls.
METHODS
Materials
The monoclonal VD111D12 anti-CSQ antibody was obtained from Afﬁnity
Bio-Reagents (Gymea, Australia). Other chemicals were from Sigma-
Aldrich (Castle Hill, Australia).
SR vesicles
Back and legmuscle was removed fromNewZealandmale white rabbits, and
SR vesicles were prepared using standard methods (27) with minor changes
(28). Brieﬂy, a crude microsomal preparation was extracted from tissue
via differential centrifugation. After sucrose gradient fractionation, RyR-
enriched heavy SR vesicles were collected from the 35%/45% interface, snap
frozen, and stored in liquid nitrogen or at 70C.
Junctional face membrane
Junctional face membrane was prepared by solubilization of RyR-enriched
heavy SR vesicles by 0.5% Triton X-100, using the methodology published
byCostello et al. (29)withminor changes (30). The junctional facemembrane
preparation contains fragments of the terminal cisternae membrane (not
membrane vesicles) (29) and associated SR proteins which face the triad
junction between the terminal cisternae and the sarcolemma. These proteins
include the RyR, CSQ, triadin, and junctin. Comparisons of native SR
vesicles (used in bilayer experiments) and solubilized junctional face mem-
brane (used in this experiment with SDS-PAGE and immunoblot) have
shown that the relative amounts of RyR, CSQ, triadin, and junctin are the
same in both preparations (26,30).
CSQ expression and puriﬁcation
CSQ was either puriﬁed from rabbit skeletal muscle tissue or recombinant
cDNA cloned and expressed in Escherichia coli and subsequently puriﬁed
by afﬁnity chromatography. To purify CSQ from tissue, junctional face
membrane fragments (prepared as above) were exposed to 0.5 M NaCl or
2 mMEGTA. After a second high-speed centrifugation at 48,0003 g for 1 h,
the supernatant containing solubilized CSQ was collected and dialyzed
overnight against either 1 mM CaCl2, 100 mM KCl, and 10 mM TES (pH
7.4) to remove residual triton X-100 for use in subsequent single channel
recording experiments, or 20 mM MOPS, 50/150 mM NaCl, and 200 mM
EGTA (pH 7.4) for analytical ultracentrifugation, stopped-ﬂow, spectro-
photometry and cross-linking experiments.
Recombinant rabbit skeletal muscle CSQ was cloned, expressed, and
puriﬁed as previously described (26). In brief, after subcloning of CSQ into a
pGEX5x1 vector (containing an N-terminal GST tag), CSQwas expressed in
E. coli strain BL21DE3 colonies and puriﬁed by glutathione sepharose 4B
chromatography. CSQwas then cleaved from theGST-glutathione sepharose
4B complex by incubation with Factor Xa for 16 h at 25C. Eluted CSQ was
dialyzed against the same buffer as muscle CSQ according to different
experiments. Puriﬁed CSQ was stored at 70C.
Electrophoresis and immunoblot—determination
of CSQ association with junctional face membrane
SDS-PAGEwas performed using the Laemmli buffer system (31) with 7.5%,
10%, or 4–15% gradient polyacrylamide gels. Immunoblot was as per
Towbin et al. (32). To determine the effect of [Ca21] on CSQ associationwith
the RyR/Tri/Jun complex, junctional face membrane was resuspended at 3
mg/ml in bilayer-like buffer containing 230 mM CsMS, 20 mM CsCl, 1mM
CaCl2, 10 mM TES (pH 7.4) in the presence of protease inhibitors (1 mg/ml
aprotinin, 1 mM benzamadine, 1 mg/ml leuopeptin, and 1 mM pepstatin A).
The suspension was divided into four 250-ml fractions and incubated at 4C
for 1 h in 1 mM, 100 mM, 1 mM, or 100 nM Ca21 after the appropriate
adjustment of [Ca21] by the addition of BAPTA: 0.9mM (for 100mMCa21),
1.4mM(for 1mMCa21), and 5.4mM(for 100 nMCa21). Fractionswere then
ultracentrifuged at 100,000 3 g for 20 min. After centrifugation, the super-
natant was removed and the pellet was resuspended in 250 ml of the bilayer-
like buffer. TheCSQcontent of the resuspendedpellets and supernatantswere
analyzed by electrophoresis and immunoblot. Images of SDS gel electro-
phoresis and immunoblot were taken by Genesnap 6.0 and quantiﬁed by
Genetools Analysis Software 3.0 (Synoptics, Cambridge, UK).
Analytical centrifugation
The relative molecular mass of CSQ is indicative of the degree of association
of CSQ molecules (i.e., monomer, dimer, or polymer). To determine relative
molecular mass at different [Ca21]s, sedimentation equilibrium experiments
were performed in a Beckman optima XL-A analytical ultracentrifuge
(Beckman Instruments, Fullerton, CA) using 12-mm double sector cells and
an An-60Ti rotor. Puriﬁed recombinant CSQ was dialyzed against 20 mM
MOPS, 50/150 mM NaCl, and 200 mM EGTA before the experiments. The
ﬁnal absorbance of sample was adjusted to 0.4–0.7 at A279. After adding an
appropriate amount of CaCl2 to achieve a ﬁnal [Ca
21] of 100 nM, 100 mM,
or 1 mM, the sample was incubated on ice for 30 min before being loaded
into the centrifugation cell. Sedimentation runs were carried out at a rotor
speed of 15,000–40,000 3 g at 10C. A higher speed centrifugation was
required to reach equilibrium at lower [Ca21] and was taken into account in
the ﬁnal analysis. The data obtained in these experiments were collected in
digital form using the step scan mode set at 1-mm radial increments. Each
data point was the average of 10 separate absorbance measurements taken
at each radial position. Finally, the molecular mass of sample was obtained
using the Ultrascan data analysis program.
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Kinetic measurements
Stopped-ﬂow spectrophotometry studies were carried out to examine the
kinetics of conformational changes in CSQ using an Applied Photophysics
(Leatherhead, UK) SX 18.MV stopped-ﬂow spectrophotometer with an
emissionmonochromator attachment for multiwavelength detection. Puriﬁed
dialyzed recombinant CSQ in one chamber was initially incubated in a
solution containing 1 mM, 100 mM, 100 nM, or 4 nM Ca21 before mixing.
The [Ca21] was then instantaneously either increased to 1 mM or 100 mM or
decreased to 100mM,100 nM, or 4 nMby rapidmixingwith dialysis buffer in
the second chamber containing appropriate amounts of CaCl2 and EGTA. In
the regular mixing mode, the contents of the chambers were symmetrically
driven into an optical cell by a ﬂush drive ram at 20C. The ﬂuorescence of the
mixed sample in the cell was measured at an emission wavelength of 295 nm
for 5, 50, or 200 s. Analysis of the data was carried out using Pro-Kineticist
software (Applied Photophysics). Intrinsic ﬂuorescence of tryptophan
residues in CSQ was measured. A change in ﬂuorescence indicated a change
in the environment of the tryptophan residues. The increase in ﬂuorescence
can be explained by a change to a less hydrophilic environment. This is
entirely consistent with the shielding of these residues that occurs upon the
formation of multimers. Conversely, a decrease in ﬂuorescence would be
observed upon dissociation into monomers.
Cross-linking
To visualize the degree of association of CSQ (i.e., dimerization or
polymerization) at various [Ca21]s, 10 mg of puriﬁed skeletal muscle or
recombinant CSQ (dialyzed as above, at a concentration of .0.5 mg/ml)
was incubated at room temperature for 10 min after the [Ca21] was adjusted
to 100 nM, 100 mM, or 1 mM in the presence of 50 mM or 150 mM NaCl
and 20 mMMOPS. The samples were further incubated with the cross-linker
20 mM 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride
(EDC) and 50 mM N-hydroxysuccinimide (NHS) for 15 min at room
temperature. The reaction was stopped by the addition of 1:1 SDS-PAGE
sample buffer and loaded on 7.5% or 4–15% gradient gel immediately for
electrophoresis and subsequent immunoblotting.
Single channel recording
Lipid bilayers were formed across a 150-mm aperture in a delrin cup, which
separated two solutions, denoted cis (cytoplasmic) and trans (luminal). The
artiﬁcial lipid composition was as follows: phosphatidylethanolamine,
phosphatidylserine, phosphatatidylcholine (5:3:2 v/v), as described previ-
ously (25). SR vesicles (50 mg) were added to the cis solution so that the
cytoplasmic surface of the SR and RyRs faced that solution after incorpo-
ration into the lipid bilayer (25). For SR vesicle incorporation, the standard
solution compositions were as follows: cis: 230 mMCsMS, 20 mMCsCl, 50
mM or 1 mM CaCl2, and 10 mM TES (pH 7.4); and trans: a), physiological
Ca21 solution: 30 mM CsMS, 20 mM CsCl, 1 mM CaCl2, and 10 mM TES
(pH 7.4); b), 100 mM Ca21 solution, with the same composition as the
physiological solution except that the [Ca21] was 100 mM; or c), 100 nM
Ca21 solution: 30 mMCsMS, 20mMCsCl, 10 mMTES, 100mMCa21, and
0.218 mM EGTA (pH 7.4). For recording, the following changes to standard
solutions were made after channel incorporation. In the cis chamber, 2 mM
ATP was added and [Ca21] was lowered to 50 mM (by the addition of 0.95
mM EGTA or 0.96 mM BAPTA) or 100 nM (by the addition of either 1.71
mM EGTA or 4.25 mM BAPTA). In the trans chamber, Cs1 was raised to
250 mM by the addition of 200 mM CsMS. When using a trans solution
with 1 mM Ca21 for incorporation, trans [Ca21] was subsequently lowered
from 1 mM to 100 mM or 1 mM (by addition of 0.9 mM or 1.3 mM BAPTA
or 0.9 mM or 1.07 mM EGTA) or from 1 mM to 100 nM (by addition of 2.95
mM BAPTA or 0.64 mM EGTA). Alternatively, when channels were
incorporated at low trans [Ca21] (100mMor 100 nM), trans [Ca21] was then
increased to 1mMby the addition of 0.9mMor 1.28mMCaCl2. All electrical
potentials are expressed here using standard physiological convention (i.e.,
cytoplasmic side relative to the luminal side at virtual ground). Single channel
recordings were obtained using bilayer potential differences of 140 or 40
mV.Measurementswere carried out at 23C6 2C.A fall in luminal pH from
7.4 to 7.0 wasmeasuredwhen EGTA (buffered to a pH of 7.4 by 10mMTES)
was added to the bilayer solutions; however, this was not sufﬁcient to alter
RyR activity (33). There was no change in pH when BAPTA, ATP, or CaCl2
were added to the solutions.
Single channel analysis
Single channel parameters were obtained using the Channel2 program
(developed by P. W. Gauge and M. Smith, John Curtin School of Medical
Research, Canberra, Australia). Channel activity was assessed from a 30-s
record and was expressed as relative open probability (Po). In this study, Po
was measured in two ways, either by using a threshold discriminator, which
is set above the baseline noise at ;20% of maximal current (this was used
where only one channel opened and allows detection of any substates of
channel openings.2 pA), or from fractional mean current (I9F), which is the
average of all data points obtained during a recording period, divided by
the maximum single channel current (used when 2 or 3 channels opened
simultaneously). For the Po measurement, records are carefully checked by
eye before analysis to make sure that the noise level is less than the level of
the threshold discriminator. Po was obtained from total open time divided by
total recording time of the channel trace (usually 30 s). The accuracy of the
I9F measurement depends on the noise level being equally distributed above
and below the baseline so that mean current is close to zero when the channel
is inactive. Therefore we corrected ﬂuctuations in baseline levels with the
program Baseline (developed by Dr. D. R. Laver, University of Newcastle,
Callaghan, Australia). I9F is approximately equal to the Po measured by thresh-
old discrimination when most of channel openings are to the maximum con-
ductance so that relative Po ¼ relative I9F. Therefore, regardless of whether Po
wasmeasured directly or as I9F, all normalized data are expressed as relative Po.
CSQ dissociation in bilayer experiments
Trans [Cs1] was increased from 250 mM (control) to 500 mM to dissociate
CSQ. This treatment has been shown to dissociate .95% CSQ from the
junctional face membrane (25). After an increase in channel activity con-
sistent with CSQ dissociation (25), the trans chamber was perfused with
control solution (250 mM Cs1) to both lower ionic strength and remove dis-
sociatedCSQ.Replacing the high ionic strength solutionwith control solution
(250 mM Cs1) did not alter channel activity, indicating that the increased
activity was caused by an irreversible event, such as CSQ dissociation, which
was seen under the same conditions using electrophoresis and immunoblot
(25). Therefore, the change in channel activity induced by high luminal ionic
strength is believed to be due to CSQ dissociation.
Statistics
Average data are presented as mean 6 SE. The signiﬁcance of differences
between control and test values was tested using an analysis of variance
(ANOVA, single factor or two-factor without replication. Two-factor was used
unless otherwise stated). A Student’s t-test for paired data or a sign test (34)
was used as appropriate. A P value of,0.05 was considered to be signiﬁcant.
RESULTS
Effects of low Ca21 on the CSQ polymer
The degree of CSQ polymerization in solutions containing
1 mM, 100 mM, or 100 nM Ca21 was determined. Puriﬁed
recombinant CSQ was exposed to each [Ca21] and then
cross-linked with the carboxyl-amine cross-linker EDC and
1290 Wei et al.
Biophysical Journal 91(4) 1288–1301
NHS. SDS-PAGE of the cross-linked CSQ showed that at
1 mM Ca21much of the CSQ existed as tetramers and higher
molecular mass polymers (i.e., CSQ at a molecular mass that
is greater than that of a tetramer, i.e., .220 kDa) at 1 mM
Ca21. The resolution at the top of the gel in Fig. 1 allows
clear identiﬁcation of hexamers. Higher molecular mass en-
tities can be seen, but their exact molecular mass not re-
solved. In contrast to the distribution at 1 mM Ca21, most of
the CSQ was monomeric at 100 mM and 100 nM. Minimal
amounts of CSQ existed as dimers or tetramers, and higher
molecular mass polymers were not observed at the lower
[Ca21] (Fig. 1 A, lanes 2–4). That the higher molecular mass
moieties were CSQ polymers was conﬁrmed by immunoblot
using anti-CSQ antibody (Fig. 1 A, lane 5). The existence of
CSQ polymers at 1 mM Ca21 is consistent with ultrastruc-
tural observations of muscle ﬁbers ﬁxed under physiological
conditions where luminal Ca21 is 1 mM. These studies show
that ribbons of CSQ believed to be CSQ polymers (16) are
associated with the junctional face membrane. Thus CSQ in
situ under physiological conditions is a polymer. The results
in Fig. 1 A show that isolated CSQ retains a largely polymer
structure if maintained in 1 mM Ca21. However, if Ca21 is
lowered to #100 mM for prolonged periods, it dissociates
into monomers.
Conformational changes with alterations in [Ca21] were
examined using stopped-ﬂow analysis of the intrinsic ﬂuo-
rescence of tryptophan residues in CSQ (Methods). When
the [Ca21] was decreased from 1 mM to 100 mM or 100 nM,
a decrease in ﬂuorescence (indicating an increased hydro-
philic environment, consistent with protein unfolding and/or
depolymerization) occurred over a 50-s period (Fig. 1 B).
When [Ca21] was raised from 100 nM or 100 mM to 1 mM,
an increase in ﬂuorescence over a similar time course in-
dicated a decreased hydrophilic environment and protein
folding and/or polymerization (Fig. 1 C). Interestingly, no
signiﬁcant change in ﬂuorescence was seen when Ca21 was
varied between 100 mM and 4 nM (Fig. 1, B and C), indi-
cating that the structural changes detected with the stopped-
ﬂow analysis mostly occurred within a physiological range
of luminal Ca21 between 100 mM and 1 mM. These changes
in ﬂuorescence occur within the period that changes were
observed in single channel activity (below) and are consis-
tent with the cross-linking data, which showed a decreased
association between CSQ moieties when [Ca21] was 100 nM
or 100 mM compared with that at 1 mM Ca21. It is not clear
whether the conformational changes detected in stopped-ﬂow
reﬂect changes in the folding and compaction of individual
CSQ molecules that precede polymerization/depolymeriza-
tion or whether it reﬂects the polymerization process itself. In
either case, the stopped-ﬂow data are indicative of effects of
Ca21 on CSQ conformation that are consistent with the ﬁnal
polymerization/depolymerization seen in the cross-linking
FIGURE 1 Cross-linking and stopped-ﬂow data
using puriﬁed recombinant CSQ suggest reversible
conformational changes including polymerization at
1 mM Ca21 and depolymerization at 100 mM and
100 nM Ca21. (A) 7.5% SDS-PAGE after cross-linking
revealed that CSQ was mainly a monomer at 100 nM
and 100 mM Ca21 (lanes 2 and 3) but existed as both
monomers and multimers at 1 mM Ca21 (lane 4).
Monomeric CSQ not exposed to cross-linker is shown
in lane 1 as a control. Immunoblot of the cross-linked
CSQ (using anti-CSQ antibody) conﬁrmed that all
bands contained CSQ and conﬁrmed the presence
of monomers and multimers at 1 mM Ca21. (B and C)
show changes in ﬂuorescence detected in a stopped-
ﬂow kinetic study at wavelength 295 nm, temperature
20C. (B) A decrease in CSQ ﬂuorescence (indicating
an increased hydrophilic environment around trypto-
phan residues) is apparent when Ca21 is lowered from
1 mM Ca21 to 100 nM or 100 mM (ﬁrst and second
panels). Only a slight decrease in the ﬂuorescence sig-
nal was detectedwhen Ca21was dropped from 100mM
to 4 nM (third panel). There was no ﬂuorescence signal
in control experiments with buffers only (fourth panel).
(C) An increase in ﬂuorescence (indicating a decreased
hydrophilic environment around tryptophan residues)
occurred when Ca21 was increased from 100 nM or
100 mM to 1 mM (top two panels). There was only a
small increase in ﬂuorescence when Ca21 was raised
from 4 nM to 100 mM (third panel). These results indicate reversible Ca21-dependent conformational changes occurring in CSQ with changes in [Ca21], and
these conformational changes mostly occur within the physiological range of 100 mM–1 mM. In control experiments, there was no change in ﬂuorescence
when buffer [Ca21] was changed in the absence of CSQ. Each record is the average of at least three experiments. The vertical scale is in arbitrary ﬂuorescence
units.
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study. Both the cross-linking and stopped-ﬂow experiments
were conducted at physiological ionic strength (150 mM
NaCl). Since it has been suggested that monovalent ions
disrupt the polymerization of CSQ (22), cross-linking was
repeated at low ionic strength (50 mM NaCl). However even
under low ionic strength conditions, minimal CSQ dimer and
tetramer formation was observed with 1 mM Ca21 (data not
shown).
Changes in CSQ conformation were also examined by
measuring particle molecular mass using analytical centrif-
ugation of puriﬁed recombinant CSQ exposed to 1 mM, 100
mM, and 100 nM Ca21 in the presence of either 150 mM or
50 mM NaCl. The apparent molecular mass was more than
twofold higher when [Ca21] was 1 mM than when [Ca21]
was 100 nM (with 150 mM NaCl, Table 1). The molecular
mass of CSQ in the presence of 100 nM Ca21 was consistent
with the calculated monomeric molecular mass for CSQ of
48 kDa. The twofold increase in apparent molecular mass is
not likely to simply reﬂect dimer formation, since the cross-
linking data show that ;45% CSQ is a monomer at 1 mM
Ca21. Since 45% monomer plus 55% dimer would give an
apparent molecular mass of only 74 kDa, higher molecular
mass entities must exist. For example, an apparent molecular
mass of;100 kDa would be consistent with 45% monomer,
37% dimer, 12% tetramer, and 6% octamer. Therefore, a
twofold increase in apparent molecular mass in 1 mM Ca21
is consistent with the coexistence of monomers, dimers,
tetramers, and the higher molecular mass forms seen in the
cross-linking study (Fig. 1 A). A similar increase in apparent
molecular mass (2.3-fold) was detected with low ionic strength
(50 mM Na1) at 1 mM Ca21 (data not shown). There was a
relatively small change in apparent molecular mass between
100 nM and 100 mM Ca21, suggesting that the protein was
mostly monomeric over this concentration range. The results
further indicate that dimerization and polymerization occur
when Ca21 is increased from 100 mM and 1 mM, as was also
indicated by the stopped-ﬂow and cross-linking data.
Effects of low Ca21 on CSQ association with the
RyR/Tri/Jun/CSQ complex
SDS-PAGE and immunoblot analysis were used to deter-
mine whether skeletal muscle CSQ did dissociate from the
RyR/Tri/Jun/CSQ complex under the same conditions in which
conformational changes were seen in CSQ when Ca21 was
lowered. Solubilized junctional face membrane (obtained
from skeletal muscle SR preparations) used in this experi-
ment contained membrane proteins with some surrounding
lipid (29). Thus the membrane pellet contained membrane
fragments with membrane proteins embedded and their
associated proteins which remained bound (e.g., the RyR/
Tri/Jun/CSQ complex or RyR/Tri/Jun complex). The solu-
bilized membrane did not form vesicles, so that proteins like
CSQ that dissociated from the luminal side of membrane
were free to diffuse into the solution. The supernatant con-
tained material that was not associated with (or had dis-
sociated from) the membrane fragments.
Solubilized junctional face membrane was exposed to
[Ca21]s of 1 mM, 100 mM, 1 mM, and 100 nM Ca21 (Fig. 2,
A and B) and the amounts of CSQ remaining in the mem-
brane pellet and the amount dissociated (and present in the
supernatant) compared with the amount found in the original
fractions (Methods). Less CSQwas associated with the mem-
brane pellet as the [Ca21] fell (Fig. 2, A and C). Quantitation
indicated that 20% of total CSQ was dissociated with 1 mM
Ca21, 62% with 100 mM Ca21, 60% with 1 mM, and 76%
with 100 nM Ca21. The immunoblot analysis conﬁrmed that
the 55-kDa protein was CSQ (Fig. 2 B). Thus, although CSQ
was removed from the RyR/Tri/Jun complex during expo-
sure to low Ca21 (particularly 100 nM Ca21), a signiﬁcant
fraction remained associated with the membrane. This was in
marked contrast to the .95% dissociation of CSQ from the
junctional face membrane when ionic strength is increased to
500 mM or when Ca21 is increased to .5 mM (25,26).
The reduction in the amount of CSQ associated with the
junctional face membrane could have been due to either
dissociation of all CSQ from a fraction of RyR/Tri/Jun com-
plexes or to partial removal of CSQ from each RyR/Tri/Jun
complex due to depolymerization of CSQ monomers not
bound to the membrane complex. The second possibility is
more likely because the data in Fig. 1 and Table 1 indicate
that CSQ was largely depolymerized when luminal Ca21
was 100 nM or 100 mM. Since depolymerized CSQ retains
its ability to associate with triadin and junctin at low Ca21
((35) and N. A. Beard, M. Varsanyi, and A. F. Dulhunty,
unpublished observation), it is likely that the residual ter-
minal CSQ remained bound to the RyR/Tri/Jun complex,
whereas the distal depolymerized CSQ dissociated from the
complex.
Effects of prolonged exposure to low luminal Ca21
on RyR channel activity
Native RyRs were incorporated into bilayers with 1 mM trans
Ca21 so that endogenous CSQ remained associated with the
RyR/Tri/Jun complex and the CSQ polymer was stabilized
TABLE 1 Sedimentation equilibrium data showing different average size of CSQ at 100 nM, 100 mM, and 1 mM Ca21 with
150 mM NaCl
100 nM Ca21 100 mM Ca21 1 mM Ca21
Molecular mass











45.33 6 1.52 1 65.24 6 2.7 1.44 97.33 6 5.13 2.15
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(20,25,29,36). Channel activity can be recorded for 30 min
or longer with multiple perfusions and addition of solutions
lacking active compounds, with no consistent changes in
activity (37). Therefore the changes in channel activity
shown in Fig. 3 and subsequent ﬁgures are speciﬁc changes
in response to changes in luminal [Ca21]. When luminal
(trans) Ca21 was reduced to 100 nM, there was little initial
change in channel activity during the subsequent 1-min
recording period (Fig. 3 B). However, after ;2–3 min, a
sudden increase in activity was observed in 16 of 16
channels (Fig. 3 C). On average, there was an ;2-fold
increase in activity after .3-min exposure to 100 nM Ca21.
When trans Ca21was returned to 1 mM, channel activity fell
but Po remained higher than control until 16 mg/ml of exog-
enous skeletal muscle CSQ was added to the solution (Fig. 3,
D and E). The concentration of 16 mg/ml CSQ (;0.39 mM)
was chosen for several reasons. First, it is the minimal
concentrations required to get observable regulation of the
RyR (30). Second, higher concentration of CSQ had no
further effect on channel activity (we tested up to 100 mg/ml,
(30)). Finally, concentrations in this range have been found
by others to regulate RyRs (15,38).
Addition of puriﬁed recombinant CSQ to RyRs under the
same conditions resulted in a similar drop in channel activity
to control levels. The delayed increase in activity, with re-
covery only after addition of exogenous CSQ, was reminis-
cent of effects of CSQ dissociation from the RyR/Tri/Jun
complex after increasing ionic strength or luminal Ca21
(25,26). The similar result was surprising since dissociation
of .95% CSQ from RyR/Tri/Jun complex with high ionic
strength and polymer stabilization (25,30) is a very different
physical process to polymer destabilization and dissociation
of distal CSQ from residual CSQ that remains bound to
triadin and junctin under low Ca21 conditions. The delay
before the increase in channel activity after reducing luminal
Ca21 was signiﬁcantly longer than the delay after increasing
luminal ionic strength or luminal Ca21 (Table 2), supporting
the hypothesis that different physical processes underpinned
the increase in activity. The increase in activity suggests that
even though ;25% of CSQ remains bound, this residual
CSQ no longer regulated the RyR even when the luminal
[Ca21] was restored to 1 mM. The fact that all channels
showed a delayed increase in activity provides further evi-
dence that some CSQ dissociated from each channel (see pre-
vious section) and hence that some CSQ also remained
associated with each channel. We have deﬁned RyRs that are
no longer regulated by the residual CSQ as CSQ-deregulated
RyRs.
Raising [Ca21] to 1 mM did not result in a full recovery of
channel activity. This was presumably because the few
molecules of CSQ that had dissociated were inﬁnitely diluted
in the 1.5-ml experimental solution and were unlikely to
reassociate with the channel complex. Channel activity was
not reduced to control levels until an appropriate CSQ con-
centration was achieved by adding excess exogenous CSQ to
the solution. We previously reported that exogenous CSQ
does not alter RyR activity when the endogenous CSQ poly-
mer is already bound but reduces activity when it binds to the
RyR/Tri/Jun complex lacking endogenous CSQ polymer
(25,26). The signiﬁcant decline in activity with CSQ addition
in these experiments suggested that the exogenous CSQ was
able to associate with the residual CSQ that remained bound
FIGURE 2 CSQ is only partially dissociated from the RyR/Tri/Jun
complex at low Ca21. Solubilized junctional face membrane was exposed to
different [Ca21]s to determine the amount of CSQ dissociation. (A) 10%
SDS polyacrylamide gel showing soluble protein which remained in the
supernatant (Sup) and membrane bound protein, which was present in
the resuspended membrane pellet (MP), obtained by centrifugation after the
junctional face membrane (JFM) had been exposed to 100 nM (lanes
1 and 2), 1 mM (lanes 3 and 4), 100 mM (lanes 5 and 6), or 1 mM Ca21
(lanes 7 and 8). Lane 9 shows the total JFM in the 1 mMCa21 buffer, before
separation into soluble and membrane fractions, so that CSQ in this lane is
the total CSQ (i.e., Sup plus MP). The position of the molecular mass
markers are shown to the left of the gel. (B) Immunoblot of protein product
shown in (A) immunostained with VIIIDl2 monoclonal anti-CSQ antibody.
An equivolume (15 mls) of JFM (3 mg/ml), resuspended pellets and
supernatant fractions (see Methods) were loaded to appropriate lanes for
both the Coomassie blue stained gel and the immunoblot. The amount of
CSQ in the supernatant increased and that associated with the pellet
decreased as [Ca21] was lowered. Arrows below the immunoblot show the
supernatant lanes that were used for quantiﬁcation. (C) Quantiﬁcation
(Methods) shows that the percentage of dissociated CSQ in the supernatant
increased as [Ca21] was lowered (n ¼ 3–6). The percentage of dissociation
was plotted as a function of [Ca21] and was ﬁtted with a sigmoid curve
equation, which indicates 50% dissociation at ;900 mM Ca21. CSQ
dissociation is presented as a percentage of the total CSQ present in the JFM
before the exposure to different [Ca21].
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to the RyR/Tri/Jun complex and restore the functional CSQ
multimer. The small, but signiﬁcant decline in activity when
trans Ca21 was initially increased to 1 mM is consistent with
the effect of luminal Ca21 per se on CSQ-deregulated RyRs
(given in Results below).
The data obtained from the stopped-ﬂow, cross-linking,
and analytical ultracentrifugation experiments suggested that
conformational changes in CSQ occurred mostly in the [Ca21]
range between 100 mM to 1 mM. To determine whether the
conformational changes in this range of [Ca21]s also led to
removal of CSQ regulation of RyRs, we examined the effect
of reducing trans Ca21 to 100 mMon single channel activity.
RyR channels were incorporated at 1 mM trans Ca21. There
was a small initial decline in channel activity when trans
Ca21 was reduced to 100 mM (by adding BAPTA), which
was greater with activating (50 mM) cis Ca21 than with
subactivating (100 nM) cis Ca21 (see also Results below).
After;7 min a sudden fourfold increase in activity was seen
at both subactivating (100 nM) and activating (50 mM) cis
Ca21 (Fig. 4 A). There was a twofold increase relative to the
initial control activity with 100 nM cis Ca21 (Fig. 4 B). The
immediate fall in Po when channels activated by 50 mM cis
Ca21 were exposed to 100 mM trans Ca21 meant that the
delayed fourfold increase did not raise Po above control val-
ues (Fig. 4 B). The sudden delayed increase in activity was
consistent with the structural data and indicates that the con-
formational changes that lead to CSQ deregulation also occur
when luminal Ca21 is reduced to #100 mM.
It should be noted that lowering luminal Ca21 from 1 mM
to 100 mM or 100 nM resulted in an increase in conductance
(apparent in Figs. 3–8) because of the removal of compe-
tition between Ca21 and Cs1 within the pore, which is well
known to reduce channel conductance (14).
Anti-CSQ antibody was used as an additional probe for
CSQ regulation of the RyR. The antibody reduces the activ-
ity of CSQ-regulated RyRs (25). After the delayed increase
in channel activity during prolonged exposure to low luminal
Ca21, the antibody was added to the trans chamber and, in
contrast to its effect on CSQ-regulated RyRs, it failed to alter
the activity of channels (Po was 0.07 6 0.003 before and
0.0736 0.004 after the addition of anti-CSQ antibody) (Fig.
4 C). This indicated that the RyRs were not regulated by the
residual CSQ. The antibody binding to CSQ does not appear
to be dependent on CSQ conformation. The antibody binds
to unfolded CSQ in immunoblots (e.g., Fig. 2 B) as well as
polymerized CSQ (25). Therefore its recognition of the CSQ
epitope does not appear to depend on CSQ structure and we
assume that it recognized the residual depolymerized CSQ
remaining bound to triadin and junctin in low Ca21 solu-
tions. However in contrast to the RyR inhibition caused
when the antibody binds to CSQ that is regulating RyR at
1 mM trans Ca21, antibody binding to the residual CSQ that
was not regulating RyR activity at 100 nM trans Ca21 failed
to alter RyR activity because there was no cross talk between
the residual CSQ and the RyR.
FIGURE 3 Native RyR channels containing CSQ
respond to low luminal Ca21 with a delayed increase
in activity. (A–E) Single channel records of 3 s of channel
activity at 40 mV. Single channel opening is upward
from zero current (c, continuous line) to maximum open
conductance (o, broken line). Cytoplasmic (cis) [Ca21]
was 100 nM in each situation. (A) Control, with 1 mM
trans Ca21; (B) 30 s after lowering trans Ca21 to 100 nM
with 4.25 mM BAPTA; (C) 3 min after lowering trans
Ca21 to 100 nM; (D) after perfusing trans chamber with
1 mM Ca21; (E) addition of 16 mg/ml CSQ; and (F)
average data (n ¼ 12–16) for relative open probability
(relative Po) at 140 mV. Asterisks (*) indicate average
values signiﬁcantly different from control, and (**) and
(##) indicate a signiﬁcant difference from the previous
condition (P , 0.05, Student’s paired t-test (*, **), and
sign test (##)).
TABLE 2 Comparison of the delay before the increase in Po






High ionic strength500 mM Cs1 17 89 11 .95
High Ca215 mM 9 110 17 .90
Low Ca21100 nM 11 203 23 ;76
A comparison of the delay before the increase in activity (Po) that signals
deregulation of the RyR by complete or partial CSQ dissociation. The
number of experiments (N) is given followed by the average time delay, the
standard errors, and then the approximate fraction of CSQ dissociated from
the junctional face membrane using high ionic strength (19), high Ca21
(42), and low Ca21 (Fig. 2, this study) detected by SDS-PAGE and im-
munoblot.
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Response of CSQ-depleted RyRs to a reduction in
luminal [Ca21]
To examine the effect of CSQ on the response of the RyR to
lowering luminal Ca21, control experiments were ﬁrst con-
ducted in the absence of CSQ. RyRs were treated with high
ionic strength to fully dissociate CSQ (CSQ(-) RyRs) (25)
and then the immediate effect of reducing trans Ca21 from
1 mM to 100 nM examined. In this experiment, cytoplasmic
[Ca21] was 100 nM. Control Po was 0.0095 6 0.003 (140
mV) and 0.051 6 0.037 (40 mV). Addition of BAPTA, to
reduce trans Ca21, resulted in a rapid (within 1 min) 2.4-fold
increase in relative Po at both positive and negative poten-
tials (Fig. 5, A and B).
Since the increase in activity could have been due to the
reduction in trans [Ca21], or an effect of BAPTA per se,
experiments were repeated using EGTA. Lowering [Ca21]
with EGTA also rapidly increased channel activity (Fig. 5,
C andD). Control Po was 0.0096 0.02 (140 mV) and 0.021
6 0.007 (40 mV) and there was a 3.5-fold increase within
1 min of reducing trans [Ca21]. A small decrease in pH from
7.4 to 7.0 was measured when EGTA (buffered to a pH of
7.4 by 10 mM TES) was added; however this was not
sufﬁcient to alter RyR activity (33). There was no change in
pHwhen BAPTAwas added to the bilayer solutions (Methods).
The similarity of the results obtained using both EGTA and
BAPTA indicated that the rapid increase in the activity of
FIGURE 4 Delayed increase in channel activity with
100 mM trans Ca21. An antibody test suggests CSQ
deregulation of RyRs with low trans Ca21. (A) Average
relative open probability (relative Po). Po after 7-min
exposure to 100 mM trans Ca21 (after the delayed
increase in activity), relative to Po with 100 mM trans
Ca21 before the delayed increase. Data are shown with
50mM cisCa21 (solid bars, n¼ 14) and 100 nM cisCa21
(striped bars, n ¼ 12). (B) Average relative Po, where Po
after 7-min exposure to 100 mM trans Ca21 is expressed
relative to Po under control conditions with 1 mM trans
Ca21. The last column in A and B shows the late increase
after 3-min exposure to 100 nM trans Ca21 (included for
comparison). (C) Channel records and average data using
the anti-CSQ antibody to test for CSQ deregulation with
100 nM transCa21. The left column shows 3-s records of
channel activity at 140 mV. Single channel opening is
upward from zero current (c, continuous line) to maxi-
mum open conductance (o, broken line). Cis [Ca21] was
100 nM. The top panel shows channel activity after the
delayed increase in activitywith exposure to 100 nM trans
Ca21; the lower panel shows activity after addition of
6mg/ml anti-CSQ antibody. The graph on the right shows
average data (n ¼ 8) for Po after the delayed increase in
activity in 100 nM trans Ca21 (ﬁrst bin) and after the
addition of the anti-CSQantibody (secondbin). Therewas
no signiﬁcant change in channel activity after antibody
addition (Student’s paired t-test).
FIGURE 5 At subactivating 100 nM cis Ca21,
lowering trans [Ca21] from 1 mM to 100 nM
activates CSQ(-)RyRs. (A–D) Records of 3 s of
single channel activity with channel opening upward
from zero current (c, continuous line) to maximum
open conductance (o, broken line) for the left panel
(140 mV) and downward from zero current (c) to
maximal open conductance (o) in the right panel
(40 mV). Cis [Ca21] was constant at 100 nM.
Trans Cs1 was increased to 500 mM to dissociate
CSQ and then lowered to 250 mM. (A) Control, with
1mM transCa21; (B) lowering transCa21 to 100 nM
with 4.25 mM BAPTA; (C–D) a repeat of A–B
except with the use of 1.75 mM EGTA to lower trans
Ca21 from 1 mM to 100 nM; and (E) average data
(n$ 5) for relative open probability (relative Po) for conditions shown in A–D at140 mV (left panel) and 40 mV (right panel) for EGTA (d) and BAPTA
(;). The arrows in E indicate the direction of trans [Ca21] change (from 1 mM to 100 nM). Asterisks (*) indicate average values signiﬁcantly different from
control (P , 0.05, Student’s paired t-test).
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CSQ(-) RyRs when Ca21 was lowered was due to the fall in
[Ca21] and was independent of the Ca21 buffer used.
Cytoplasmic [Ca21] did not signiﬁcantly alter the re-
sponse of CSQ(-) RyRs to a fall in luminal [Ca21]. The
experiments were repeated with a cis [Ca21] of 50 mM
(activating [Ca21]). The results in Fig. 6 again show an
increase in CSQ(-) RyR activity when trans [Ca21] was
lowered. Activity immediately increased 2.1-fold from con-
trol levels after reducing Ca21 to 1 mM (control Po was
0.016 6 0.003 (140 mV) and 0.082 6 0.028 (40 mV)).
An additional, potential-independent increase in activity was
observed after trans [Ca21] was further lowered to 100 nM
(Fig. 6). The subconductance activity apparent in the channel
in Fig. 6 was typical of that seen in many RyR channels,
particularly under conditions promoting long open times (cis
Ca21 of 1–100 mM and/or .0.5 mM ATP; A. F. Dulhunty,
unpublished observations). Therefore the subconductance
activity was more clearly seen when luminal Ca21 fell and
open times became longer (as is also seen in the channel in Fig.
3 above)—it did not appear to be speciﬁcally related to trans
[Ca21].
Next we examined how RyRs that were partially depleted
of CSQ (and relieved of normal CSQ regulation by pro-
longed exposure to low luminal Ca21) responded to changes
in luminal [Ca21]. RyRs were incorporated with a trans
[Ca21] of 100 nM at both activating (50 mM) and sub-
activating (100 nM) cis Ca21. The usual delayed increase in
channel activity, associated with the onset of CSQ deregu-
lation, was observed ;3 min after incorporation. RyRs re-
lieved of CSQ regulation in this way responded to an increase
in trans [Ca21] to 1 mM with an immediate and sustained
decrease in activity when cis Ca21 was 50 mM (Fig. 7). A
similar decrease in activity was seen in ﬁve experiments with
100 nM cis Ca21 (data not shown). Although the fall in
channel activity was signiﬁcant at both 140 and 40 mV,
the effects were most pronounced at negative potentials, with
relative Po being reduced to almost 20% of that recorded in
100 nM Ca21. Using a similar protocol, channels were in-
corporated at 100 mM trans Ca21. In this case there was an
increase in activity after ;7 min, which suggested that CSQ
regulation was removed. An increase in trans Ca21 to 1 mM
was then accompanied by decrease in channel activity to
;30%, similar to the decrease seen when Ca21 was in-
creased to 1 mM after incorporation at 100 nM trans Ca21
(Fig. 7 B). In conclusion, the response of CSQ-deregulated
RyRs to changes in luminal Ca21 between 100 nM (or
100 mM) and 1 mM was the same as the response of CSQ(-)
RyRs. These experiments conﬁrmed that, in the absence of
an inﬂuence from CSQ, RyRs were more active at 100 nM or
100 mM trans Ca21 than at 1 mM, and this occurred when
trans Ca21 was either reduced from high (1 mM) to low (100
mM or 100 nM) or increased from low (100 mM or 100 nM)
to high (1 mM) concentrations.
Response to reduced luminal [Ca21] when RyRs
were not treated to dissociate CSQ
In the following experiments, RyRs were incorporated into
bilayers with 1 mM trans Ca21 to maintain the RyR/Tri/Jun/
CSQ complex. The channels were not treated to dissociate
CSQ (they were presumed to be associated with CSQ) and
are referred to as ‘‘untreated’’ RyRs. Trans [Ca21] was
lowered to 100 mM or to 1 mM and then to 100 nM at both
subactivating (100 nM) and activating (50 mM) cis [Ca21]s.
Although the low trans Ca21 does dissociate;25% of CSQ,
changes in channel activity associated with this process are
slow (.3 min with 100 nM Ca21 and .7 min with 100 mM
Ca21, data above), in contrast to the immediate luminal
Ca21-dependent changes in activity, which reﬂect the re-
sponse of the RyR when it is regulated by CSQ. Therefore
the response of channels to the change in trans Ca21 was
measured within;1 min of the addition of the Ca21 chelator
and a stirring step of 20 s, well before the delayed increase in
channel activity was seen. In contrast to CSQ(-) RyRs, there
was no immediate increase in the activity of these untreated
RyRs when trans Ca21 was reduced from 1 mM (to 100 mM
or 100 nM) and the response of the untreated channels did
depend on the cytoplasmic (cis) [Ca21]. Channels examined
with a cis Ca21 of 100 nM had a Po of 0.078 6 0.009 with
1 mM luminal Ca21. Reducing luminal [Ca21]s had little
FIGURE 6 Lowering trans [Ca21] from1mMto100nM
activates CSQ(-) RyRs in channels activated by cis
Ca21. (A–C)Records of 3 s of channel activity at40mV.
Single channel opening is downward from zero current
(c, continuous line) to maximum open conductances
(o, broken lines). Cis [Ca21] was 50 mM. Trans Cs1 was
increased to 500 mM to dissociate CSQ and then lowered
to 250 mM. (A) Control, with 1 mM trans Ca21; (B) after
lowering trans Ca21 to 1 mM with 1.07 mM EGTA; (C)
after lowering transCa21 to 100 nM by a further addition
of 0.64 mM EGTA; and (D) average data (n ¼ 6) for
relative open probability (relativePo) at40mV (¤), and
at 140 mV (n), plotted as a function of trans [Ca21].
Asterisk (*) indicate average values signiﬁcantly different
from control (P , 0.05, ANOVA). The arrow in D indi-
cates the direction of trans [Ca21] change.
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effect on their activity, with no signiﬁcant effect on the
average relative Po (Fig. 8, A–E, left). Two out of thirty-two
channels with 100 nM cis Ca21 responded in a potential-
dependent manner (slight increase in activity at the negative
potential, but a decrease at the positive potential), similar to
the effect reported by Laver et al. (39). Nevertheless, overall
there was no signiﬁcant change when lowering trans Ca21
from 1 mM to 100 mM at 100 nM cis Ca21. In contrast, when
the untreated channels were exposed to 50 mM cis Ca21,
lowering trans Ca21 to 100 mM or to 100 nM caused a
signiﬁcant reduction in channel activity immediately after
adding the Ca21 chelating agents to the trans chamber (Fig.
8, A–E, right). When trans Ca21 was lowered from 1 mM to
100 mM, there was a decrease in RyR activity with activating
(50 mM) cis Ca21 from Po of 0.19 6 0.03 to 0.072 6 0.009
(combined data at 140 and 40 mV).
In this series of experiments, a late increase in activity was
again observed with 100 nM and 100 mM trans Ca21 (data
not shown), which presumably reﬂected CSQ depolymer-
ization and partial dissociation from the RyR complex. Both
the lack of a change in initial activity of the untreated chan-
nels when luminal Ca21 was lowered in the presence of 100
nM cis Ca21 and the reduction in activity observed with
50 mM cis Ca21 were in marked contrast to the signiﬁcant
increase in activity seen when the same experiments were
performed with CSQ(-) RyRs.
DISCUSSION
These novel results clearly demonstrate time-dependent
conformational changes in CSQ when luminal Ca21 is low-
ered from 1 mM to 100 mM, with little additional change
when Ca21 was further lowered to 100 nM. Consistent
changes were observed in cross-linking, stopped-ﬂow spec-
trophotometry, and sedimentation equilibrium coefﬁcient
experiments. These structural changes, likely to include depo-
lymerization, occur under the same conditions as dissocia-
tion of a fraction of CSQ from the junctional face membrane.
Nevertheless, a signiﬁcant amount of the monomeric CSQ
remained associated with the membrane. The destabilization
of the polymer with low luminal Ca21, like complete CSQ
dissociation with high ionic strength, leads to an increase in
RyR activity. We show for the ﬁrst time that the response of
the RyR to a fall in trans [Ca21] to below normal phys-
iological concentrations of 1 mM depends not only on the
presence of CSQ but also on its structure. In the absence of
CSQ or when CSQ is mostly in a monomeric form, the
activity of RyRs increased rapidly (,1 min) when trans
FIGURE 8 Lowering trans [Ca21] to 100mM and
100 nM inhibits native untreated RyRs activated by 50 mM
cis Ca21. (A–D) Records of 3 s of single channel activity,
at both 140mV (A–B) and 40 mV (C–D). Single
channel opening is upward from zero current (c;
continuous line) to maximum open conductance (o;
broken line) at 140 mV and downward at 40 mV. Cis
[Ca21] was either 100 nM (left panels) or 50 mM (right
panels). (A and C) Control, with 1 mM trans Ca21 at
140 and 40 mV, respectively; (B and D) lowering
trans Ca21 to 100 nMwith 4.25 mMBAPTA at140 and
40 mV, respectively; and (E) average data for relative
open probability (relative Po) as a function of trans
[Ca21]. Data obtained at subactivating (100 nM;:) and
activating (50 mM; d) cis Ca21 (n ¼ 9–24). Asterisks (*) indicate average values signiﬁcantly different from control (P , 0.05, Student’s paired t-test). The
arrow shows the direction of the trans [Ca21] change (in this case, from 1 mM to 100 mM or 100 nM).
FIGURE 7 Increasing trans [Ca21] from 100 nM or
100 mM to 1 mM results in inhibition of native CSQ-
deregulated RyR channels activated by cis Ca21. (A–C)
Records of 3 s of channel activity at 40 mV. Single
channel opening is downward from zero current (c,
continuous line) to maximum open conductance (broken
lines, o1 and o2). Cis [Ca
21] was constant at 50 mM. (A)
Control, with 100 nM trans Ca21; (B) after increasing
trans Ca21 to 1 mM by the addition of 1.28 mM CaCl2;
and (C) average data for relative open probability
(relative Po) after 100 nM trans Ca
21 incorporation
(n¼ 14) (:) and with 100 mM trans Ca21 incorporation
(n ¼ 8)(d). Data are plotted as a function of trans
[Ca21]. A decrease in channel activity when trans Ca21
was raised from 100 nM or 100 mM to 1 mM in these CSQ-deregulated RyRs shows the same response to luminal Ca21 as CSQ(-)RyRs. Asterisks (*) indicate
average values signiﬁcantly different from control (P , 0.05, Student’s paired t-test). The arrow shows the direction of the trans [Ca21] change (in this case,
from 100 nM or 100 mM to 1 mM).
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[Ca21] was lowered to 100 mM, 1 mM, or 100 nM and did
not change further during long exposures to the low trans
[Ca21]. In contrast, when CSQ had not been intentionally
dissociated or structurally altered, a brief exposure to low
trans [Ca21] did not cause any change in channel activity
when the cytoplasmic [Ca21] was at resting levels (100 nM)
and consistently reduced the activity of channels exposed to
an activating cytoplasmic [Ca21] of 50 mM. The results
show clearly that CSQ multimer association with the Ca21
release channel prevents the increase in channel activity that
occurs in its absence and helps conserve Ca21when the store
concentrations are low.
CSQ dissociation and depolymerization after
exposure to low Ca21
CSQ was partially dissociated from the solubilized junc-
tional face membrane when [Ca21] was lowered to 100 mM,
1 mM, or 100 nM. Indeed, CSQ has been reported to change
from a random coil to a folded monomer, dimer, and polymer
as the [Ca21] rises from 0 to 1 mM (9,21,40,41) although the
exact [Ca21] which induces each conformation had not been
determined. Our cross-linking data suggest that CSQ is
mostly monomeric (with minimal amounts of dimers and
tetramers) when [Ca21] is between 100 nM and 100 mM and
that signiﬁcant dimerization, tetramerization, and higher
molecular mass constructs form over a relatively narrow and
physiological range of [Ca21]s between 100 mM and 1 mM.
Our results show conclusively that a), the majority of CSQ
forms multimers at 1 mM Ca21 but that the monomeric CSQ
is stabilized at [Ca21]s between 100 nM and 100 mM, b),
;25% of the CSQ remains associated with the junctional
face membrane even after exposure to [Ca21]s as low as
100 nM, c), prolonged exposure to 100 mM or 100 nM Ca21
causes a delayed rise in channel activity, d), this rise in
activity can only be reversed by the addition of exogenous
CSQ, and e), the change in activity is identical to that ob-
served with full CSQ dissociation from the native skeletal
RyR induced by high ionic strength or high Ca21 (25,26).
Shin et al. (35) reported that skeletal CSQ can associate with
triadin and junctin at low Ca21 levels, based on results from
fusion protein afﬁnity chromatography. We have conﬁrmed
this observation (N. A. Beard and A. F. Dulhunty, unpub-
lished observations). Therefore we suggest that low luminal
Ca21 causes CSQmonomerization and dissociation of all but
residual CSQ, which remains bound to the RyR/Tri/Jun
complex. This differs from full CSQ dissociation with high
ionic strength or [Ca21]s .5 mM, where CSQ binding to
triadin and junctin is disrupted, probably because the
polymer is stabilized or supercompacted as it is with
.1 mM Ca21. Since both mechanisms produce the same
changes in channel activity, we speculate the depolymeriza-
tion (or monomer formation) prevented the residual CSQ
from regulating RyR activity. This was conﬁrmed when
RyRs in this situation responded to changes in luminal Ca21
in the same way as RyRs lacking any associated CSQ. The
observation that a small fraction (,20%) of CSQ was
dissociated at the physiological [Ca21] (1 mM) could explain
the observation that a small fraction of channels lack CSQ
under control conditions (25).
The conformational changes in CSQ as a result of changing
[Ca21] between 100 mM or 100 nM and 1 mM in stopped-
ﬂow spectrophotometry experiments were two to three times
faster than the changes seen in channel activity after changing
[Ca21]. The times are nevertheless within the same order of
magnitude and the differences can be largely attributed to the
very different mixing rates in the two types of experiments.
Comparison with previous studies of the RyR
activity at low and physiological luminal Ca21
Our results with CSQ-regulated RyRs (at 100 nM and
100 mM luminal Ca21; Fig. 8) are consistent with results
obtained in more intact preparations, which show an increase
in Ca21 release when store load is increased. This increase
occurs over and above the changes in driving force on Ca21
ions (4,8). We show for the ﬁrst time that, under otherwise
identical conditions, the effects of luminal Ca21 differ de-
pending on the presence or absence of regulation by the Ca21-
binding protein CSQ. The increase in CSQ-deregulated RyR
activity observed when luminal Ca21 was dropped from
1 mM to #100 mM is similar to the activation observed
when puriﬁed RyRs (also lacking CSQ) are exposed to low
luminal Ca21 (10,11,42). However other divergent results
obtained in different laboratories cannot be simply explained
in terms of CSQ regulation, since activation and inhibition
have been seen in both native RyRs, potentially containing
CSQ/Tri/Jun (1,13,14,42), and puriﬁed RyRs where these
associated proteins are likely to be absent (10,12,43,44).
Therefore, some of the different reported effects of lowering
luminal Ca21 on RyR activity must be due to factors other
than the presence or absence of CSQ.
Interestingly, and in contrast to the results shown here,
Laver et al. (39) reported that untreated RyRs (presumably
containing CSQ) did not respond to a fall in luminal Ca21 to
nM levels when cis Ca21 was at activating concentrations
(with other conditions similar to those in these experiments).
However, in the majority of those experiments bilayers
contained multiple channels which exhibited coupled gating
under some conditions (39). The channels had much higher
Po values than we report for experiments with one or at the
most two active channels under similar conditions. It is
possible that coupled and uncoupled channels respond quite
differently to changes in luminal Ca21. In addition, high Po
channels may be oxidized (45,46). These possibilities remain
to be investigated. The results support our contention that
there are multiple Ca21 sensors on the luminal side of the
RyR channel complex (see below). Thus it is possible that
different procedures employed in different laboratories allow
a dominant effect of one or another of the Ca21 sensors.
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The location of the luminal Ca21 sensors
We show that the activity of CSQ-deregulated RyRs in-
creases when luminal [Ca21] falls. This increase in activity
must be due to an effect of the low [Ca21] on the luminal side
of the RyR/Jun/Tri complex or on some other luminal-
associated proteins. Since the high ionic strength CSQ
dissociation procedure and the low Ca21 CSQ-deregulation
process both leave triadin, junctin, and other proteins as-
sociated with the RyR in place (25), the Ca21 sensor could
either be on the luminal domain of the RyR, on triadin or
junctin or another associated protein. It is possible that the
Ca21 sensor in this case corresponds to the luminal Ca21 in-
hibition site detected after tryptic digestion of luminal pro-
teins (14). In contrast to native skeletal preparations, puriﬁed
cardiac RyRs (with added triadin and junctin) did not
respond to changes in luminal Ca21 from 20 mM to 5 mM
until cardiac CSQ was added (15). This suggests either that
an additional Ca21-sensitive protein was removed during
puriﬁcation or that communication of store load to RyRs
differs from that in skeletal muscle.
The physiological role of CSQ as a luminal SR
Ca21 sensor for the RyR
Our observation that channel activity is higher when luminal
Ca21 is 1 mM (than with 100 nM or 100 mM) in the presence
of CSQ (with activating cis [Ca21]s) is consistent with
experiments in isolated vesicles and intact (skinned) ﬁbers,
which show that the amount of Ca21 released increases as
store load increases (4,8). Also consistent with these obser-
vations in vesicles and skinned ﬁbers is the fact that RyR
activity increases further when luminal [Ca21] is increased
above 1 mM (Fig. 9) (25,26). It is likely that CSQ depoly-
merization also occurs in skinned ﬁber and isolated SR when
the SR is severely depleted of Ca21 and free luminal [Ca21]
starts to drop (4,8). It was recently shown that SR Ca21
levels transiently fall by as much as 10% after one Ca21
release, initiated by an action potential and to levels close to
100 mM during prolonged release initiated by lowMg21 (47)
and this was attributed to CSQ depolymerization. Our results
show for the ﬁrst time, to our knowledge, that CSQ dis-
sociation does occur within this range of [Ca21] but suggest
that it would occur as a result of (and not cause) the fall in
[Ca21] . The time course of our stopped-ﬂow and single
channel changes suggests that CSQ depolymerization is too
slow to cause any signiﬁcant changes after an action poten-
tial. The whole cell system differs from the bilayer system in
that dissociated CSQ is contained within the small volume of
the terminal cisternae and it is available to reassociate with
the residual RyR/Tri/Jun-associated CSQ as soon as Ca21
loading increases luminal Ca21 to levels approaching 1 mM.
It is important to note that the activity of untreated chan-
nels that were activated by a cis [Ca21] of 50 mM in fact fell
signiﬁcantly when the trans [Ca21] was lowered. This sug-
gests that CSQ may be particularly effective in reducing
channel activity during skeletal excitation contraction cou-
pling when the normal Mg21 inhibition is relieved and
channels can be activated by Ca21 (48,49). Thus, the overall
effect of the association of CSQ with the RyR is to store
[Ca21] and to prevent an increase in channel activity under
conditions when the store is depleted (Fig. 9).
The situation in SR vesicles and in vivo is complicated by
the fact that CSQ changes structure and stops regulating the
RyR when luminal Ca21 is lowered in a time-dependent
manner. Thus it could be argued that CSQ regulation of the
RyR can protect the SR from excess Ca21 release only when
Ca21 is transiently depleted, not during prolonged depletion.
However, this may not necessarily be the case because of the
very different geometrical constraints on CSQ in the SR and
in the bilayer situation. In addition, depolymerization is
slower when [Ca21] is depleted to 100 mM, for example, so
that the store would be protected for correspondingly longer
periods with less depletion.
The physiological signiﬁcance of Ca21 sensors other than
CSQ, which produce an increase in channel activity when
luminal Ca21 falls, is not clear and is perhaps largely irrele-
vant for mature muscle ﬁbers containing the normal com-
plement of CSQ. An increase in channel activity when
luminal Ca21 is low would help maintain Ca21 ﬂuxes, but
this would be detrimental in maintaining store load. It may
well be that the Ca21-dependent inhibition seen in CSQ-
deregulated channels is a result of nonspeciﬁc conforma-
tional changes in luminal domains of the protein with the
change in [Ca21]. None of the effects of reducing luminal
Ca21 that we observe were voltage dependent (with the ex-
ception of 2 of 40 channels, see Results section) and thus
cannot be attributed to luminal Ca21 feeding through to bind
to Ca21 activation sites on the cytoplasmic domain of the
RyR (12,43). Another situation in which we saw an increase
FIGURE 9 Composite diagram of effects of increasing or decreasing
luminal [Ca21] on RyR activity in the presence or absence of CSQ. The
ﬁgure provides a general summary of data presented in this article and in
some previously published works (18,19,21,42). The data have been
recalculated so that they are expressed relative to the activity of the CSQ-
regulated RyRs in the presence of 1 mM luminal Ca21. CSQ-deregulated
RyRs have a higher open probability than CSQ-regulated RyRs under all
conditions. CSQ regulation has the strongest effect on RyR activity when
luminal Ca21 is dropped below 1 mM. It is notable that cytoplasmic Ca21
has a minimal effect on the response of the RyR to luminal Ca21 regardless
of whether the RyR is CSQ regulated or CSQ deregulated.
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in activity as luminal Ca21 increased was under conditions in
which the channels were already activated by a cytoplasmic
[Ca21] of 50 mM. Once again this cannot be attributed to a
feed though effect. Clearly, the location of Ca21 sensors that
respond to changes in luminal [Ca21] in the absence of CSQ
regulation requires further investigation.
In conclusion, the results show that the response of native
RyR channels to a fall in luminal [Ca21] differs in the pres-
ence and absence of the Ca21-binding protein, CSQ, and
thus provides evidence that CSQ is a dominant luminal Ca21
sensor for the RyR. However, this role of CSQ was main-
tained only if CSQ retained its normal multimeric confor-
mation. The fact that RyR activity changes in response to
luminal [Ca21] in the absence of CSQ conﬁrms that there are
multiple luminal Ca21 sensors. The existence of multiple
sensors could potentially allow a complex response of the
RyR to changes in luminal [Ca21], which can be modiﬁed by
a variety of conditions impinging on the Ca21 release chan-
nel. The action of CSQ in suppressing an increase in RyR
activity with store depletion is consistent with our hypothesis
that CSQ acts to maintain store Ca21 when the store is
depleted.
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